Question

Which of the following statements about the use of a short-acting inhaled beta2 agonist in asthma management is accurate for the nurse to convey to the attendee?

A) Short-acting inhaled beta2 agonists are used as long-term controllers for asthma.
B) These medications should be taken daily, regardless of asthma symptoms.
C) Short-acting inhaled beta2 agonists are primarily used to relieve acute asthma symptoms during an attack.
D) They are typically used to prevent asthma attacks from occurring.

Answer 1

Short-acting inhaled beta2 agonists are primarily used to relieve acute asthma symptoms during an attack.

Step-by-step explanation:

The accurate statement for the nurse to convey to the attendee is C) Short-acting inhaled beta2 agonists are primarily used to relieve acute asthma symptoms during an attack. Short-acting inhaled beta2 agonists, such as albuterol, provide quick relief by relaxing the muscles around the airways and opening them up, making it easier to breathe during an asthma attack. These medications are not used as long-term controllers for asthma and should not be taken daily, unless directed by a healthcare provider. Long-term control medications are used to prevent asthma attacks from occurring.